Hemodynamic management of subarachnoid hemorrhage (Q37904848)

25 August 2017

1 reference

title

Hemodynamic management of subarachnoid hemorrhage (English)

1 reference

25 August 2017

1 reference

Miriam M Treggiari

1

1 reference

25 August 2017

Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage

series ordinal

2

1 reference

25 August 2017

publication date

1 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

15

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

329-335

1 reference

Comparison of the cerebral effects of dopamine and norepinephrine in severely head-injured patients

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Direct comparison of cerebrovascular effects of norepinephrine and dopamine in head-injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Which H is the most important in triple-H therapy for cerebral vasospasm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Effect of human albumin administration on clinical outcome and hospital cost in patients with subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Effect of Hypertonic Saline on Cerebral Blood Flow in Poor-Grade Patients With Subarachnoid Hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Evaluation of therapeutically induced hypertension in patients with delayed cerebral vasospasm by xenon-enhanced computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Acute cerebral blood flow response to dopamine-induced hypertension after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

The dopamine withdrawal test following surgery for intracranial aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Normovolaemic induced hypertension therapy for cerebral vasospasm after subarachnoid haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage. Direct effect on cerebral blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Increases in Cardiac Output Can Reverse Flow Deficits from Vasospasm Independent of Blood Pressure: A Study Using Xenon Computed Tomographic Measurement of Cerebral Blood Flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Loss of cerebral regulation during cardiac output variations in focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Relationship between cardiac output and cerebral blood flow in patients with intact and with impaired autoregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Levosimendan in cardiac failure after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Cerebral vasospasm and concurrent left ventricular outflow tract obstruction: requirement for modification of hyperdynamic therapy regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Intra-aortic balloon pump counterpulsation in the setting of subarachnoid hemorrhage, cerebral vasospasm, and neurogenic stress cardiomyopathy. Case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Conservative treatment of ruptured vertebrobasilar dissecting aneurysm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Unruptured intracranial aneurysms and the assessment of rupture risk based on anatomical and morphological factors: sifting through the sands of data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Blood-flow characteristics in a terminal basilar tip aneurysm prior to its fatal rupture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Risk of aneurysm rupture at intracranial arterial bifurcations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Comparison of blood pressure-associated risk of intracerebral hemorrhage and subarachnoid hemorrhage: Korea Medical Insurance Corporation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-011-9589-5

Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage

21 January 2018

1 reference

12 December 2020

A comparison of the effects of norepinephrine, epinephrine, and dopamine on cerebral blood flow and oxygen utilisation

1 reference

12 December 2020

Current practices of triple-H prophylaxis and therapy in patients with subarachnoid hemorrhage

1 reference

12 December 2020

Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy

1 reference

12 December 2020

Effects of intravascular volume expansion on cerebral blood flow in patients with ruptured cerebral aneurysms

1 reference

12 December 2020

Enhancement of cerebral blood flow using systemic hypertonic saline therapy improves outcome in patients with poor-grade spontaneous subarachnoid hemorrhage

1 reference

12 December 2020

Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Treatment of aneurysmal hemiplegia with dopamine and mannitol

1 reference

12 December 2020

Prehemorrhage risk factors for fatal intracranial aneurysm rupture

1 reference

12 December 2020

Postoperative hypertension in the management of patients with intracranial arterial aneurysms

1 reference

12 December 2020

Intra-aortic balloon pump counterpulsation in the management of concomitant cerebral vasospasm and cardiac failure after subarachnoid hemorrhage: technical case report

1 reference

12 December 2020

Is aspect ratio a reliable predictor of intracranial aneurysm rupture?

1 reference

12 December 2020

Anticoagulation and induced hypertension after endovascular treatment for ruptured intracranial aneurysms

1 reference

12 December 2020

Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management

1 reference

12 December 2020

Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial

1 reference

12 December 2020

Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study

1 reference

12 December 2020

Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution ("triple-H" therapy) after subarachnoid hemorrhage.

1 reference

12 December 2020

Evaluation of changes in circulating blood volume during acute and very acute stages of subarachnoid hemorrhage: implications for the management of hypovolemia

1 reference

12 December 2020

Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases

1 reference

12 December 2020

10.1007/S12028-011-9589-5

Identifiers

DOI

1 reference

25 August 2017

1 reference